Remove Clinical Trials Remove Gerontology Remove Medicine Remove Trials
article thumbnail

Looking ahead to new biomarkers, clinical trials, and potential treatments for Alzheimer’s

Scienmag

NIA experts available to share context and insight on latest research shared at CTAD WHAT: National Institute on Aging (NIA) experts will be available to further explain and analyze some of the latest research as presented at the 13th Annual International Conference on Clinical Trials for Alzheimer’s Disease (CTAD).

article thumbnail

Keck Medicine of USC enrolling individuals in phase 3 clinical trial to treat mild Alzheimer?s disease using deep brain stimulation

Scienmag

While FDA-approved technique is used to treat other medical conditions, this study examines its effects on cognitive function Credit: Image courtesy of Ricardo Carrasco III of Keck Medicine of USC LOS ANGELES — An estimated 5.5 Keck […].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Insilico Medicine gets $255 million to boost AI-powered R&D, announces a collaboration

Scienmag

Credit: Insilco June 22, 2021, New York / Hong Kong — Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million from biotechnology experts to progress Insilico Medicine’s current therapeutic programs into (..)

article thumbnail

Global trial reveals life saving drug for acute myeloid leukemia

Scienmag

The Phase 3 clinical trial showed that the drug, called CC-486, significantly improved survival in older patients, over the age of 55, with AML A landmark paper published today in the New England Journal of Medicine describes the results from a global trial across 148 sites in 23 countries, showing a 30 per cent improvement […].

Trials 40
article thumbnail

Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen

Scienmag

Credit: Insilico Tuesday, November 10, 2020 (9AM Beijing) – Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharmaceutica N.V.

Drugs 53
article thumbnail

Re-envisioning mental health treatment using clinical VR

pharmaphorum

In late 2006, BRAVEMIND was tested in San Diego, California, at the Naval Medical Center and Camp Pendleton, and good clinical data was obtained in the initial open clinical trials. Other groups started to adopt the platform, which led to more research as to its clinical efficacy. VR clinical trials.

article thumbnail

Music improves older adults’ sleep quality

Scienmag

Listening to music before going to be can improve sleep quality among older adults, according to an analysis of all relevant published clinical trials. In the analysis, which is published in the Journal of the American Geriatrics Society, five randomized trials met the investigators’ criteria.